ParcelShield, a technology and data analytics company committed to transforming logistics and parcel management for healthcare, today announced that two new hires have joined the company’s executive team. They are Neil Garnichaud, who will serve as Chief Product & Technology Officer, and Scott Helfrich, who will be the new Chief Commercial Officer.
“It’s not every day that two top-tier executives, each with deep experience in technology, sales and marketing in the healthcare industry, join our executive team!” said Guillermo Sollberger, CEO of ParcelShield. “We could not be happier to welcome Scott and Neil aboard as we work to revolutionize how healthcare is delivered. Their combined business and finance acumen will help take us to the next level as our technology eliminates entrenched problems associated with parcel delivery.”
Garnichaud brings 30 years of experience in operations, project management and technology in industries ranging from finance, software, and medical technology. While serving as CTO at AssistRx, he built and maintained development, product, project management, QA, and operations organizations. Prior to that, he was VP and General Manager of SmartBear Software where he had P&L responsibility for three acquisitions. Garnichaud previously served CTO for Digital Mediums and PCLender. He started his career at BankBoston.
Helfrich has more than 28 years of sales and marketing experience, most recently serving as Chief Client Officer at nThrive where he was responsible for commercial growth in revenue and new bookings, advisory engagements, account management, channel partnerships, and commercial operations across the company’s portfolio of solutions. Prior to that, Helfrich was Chief Marketing and Sales Officer for U.S. Preventative Medicine. He also served as Vice President and General Manager of McKesson where he developed M&A integration plans for 10 acquisitions. He earned his BA in Finance from Parker College of Business-Georgia Southern University and his MBA from the University of North Florida.